■肩峰下撞击综合征(SIS)是肩痛的最常见原因。针灸是一种对疼痛有效的传统医学。本研究旨在评价针刺治疗疼痛的效果,函数,与假针灸相比,诊断为SIS的患者的活动范围(ROM)和生活质量。
■随机,prospective,双盲,进行了假对照试验.在针灸组中,40名参与者接受了针灸治疗加运动疗法,而在对照组中,40名参与者接受了假针灸加运动疗法。主要结果包括疼痛休息,活动和夜间疼痛。次要结果包括功能[肩痛和残疾指数(SPADI)和手臂残疾,肩手得分(快速DASH)],ROM,SIS患者的生活质量[西安大略肩袖指数(WORC)]。
■两组在止痛方面均有显著改善,夜间活动疼痛评分,SPADI,治疗后和第一个月随访时的QuickDASH和WORC。在治疗后和随访的第一个月,针刺组的所有ROM均有显着改善,而对照组仅在被动内部旋转中。针灸组对QuickDASH有更好的改善,WORC和所有ROM参数处理后,以及除疼痛夜间和第1个月随访时的被动屈曲外的所有参数。
■这项研究表明,针灸治疗是安全的,SIS患者的有效和非侵入性治疗选择。
■研究方案在clinicaltrials.gov(NCT05794633)注册。
UNASSIGNED: Subacromial impingement syndrome (SIS) is the most common cause of shoulder pain. Acupuncture is a traditional medicine that is effective on pain. This study aimed to evaluate the effect of acupuncture treatment on pain, function, range of motion (ROM) and quality of life compared to sham acupuncture in patients diagnosed with SIS.
UNASSIGNED: A randomized, prospective, double-blinded, sham-controlled trial was conducted. In acupuncture group 40 participants received acupuncture treatment plus exercise therapy while in control group 40 participants received sham acupuncture plus exercise therapy. Primary outcomes included pain-rest, activity and night pain. Secondary outcomes included function [Shoulder Pain and Disability Index (SPADI) and The Disabilities of the Arm, Shoulder and Hand Score (Quick DASH)], ROM, and quality of life [The Western Ontario Rotator Cuff Index (WORC)] in patients with SIS.
UNASSIGNED: Both groups had significant improvements for pain-rest, activity night pain scores, SPADI, Quick DASH and WORC after treatment and at the first month follow-up. Significant improvements were recorded in the acupuncture group for all ROM after treatment and at the first month follow-up while in control group only in passive internal rotation. Acupuncture group had better improvements for Quick DASH, WORC and all ROM parameters after the treatment, as well as for all parameters except pain-night and passive flexion at the first month follow-up.
UNASSIGNED: This study suggest that acupuncture treatment is a safe, effective and non-invasive treatment option in patients with SIS.
UNASSIGNED: The study protocol is registered at clinicaltrials.gov (NCT05794633).